Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Said, Farschtschi"'
Autor:
Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Hector Salvador, Amedeo A. Azizi, Victor Mautner, Claas Röhl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink, Joan Brunet, Frank Van Calenbergh, Catherine Cassiman, Thomas Czech, María José Gavarrete de León, Henk Giele, Susie Henley, Conxi Lazaro, Vera Lipkovskaya, Eamonn R. Maher, Vanessa Martin, Irene Mathijssen, Enrico Opocher, Ana Elisabete Pires, Thomas Pletschko, Eirene Poupaki, Vita Ridola, Andre Rietman, Thorsten Rosenbaum, Alastair Santhouse, Astrid Sehested, Ian Simmons, Walter Taal, Anja Wagner
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101818- (2023)
Summary: Background: Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder, predisposing development of benign and malignant tumours. Given the oncogenic potential, long-term surveillance is important in patients with NF1. Proposals for NF
Externí odkaz:
https://doaj.org/article/413a0a790cef49bea14006073668941d
Autor:
Lennart Well, Kimberly Döbel, Lan Kluwe, Peter Bannas, Said Farschtschi, Gerhard Adam, Victor-Felix Mautner, Johannes Salamon
Publikováno v:
PLoS Genetics, Vol 17, Iss 5, p e1009517 (2021)
Neurofibromatosis type-1 (NF1) patients suffer from cutaneous and subcutaneous neurofibromas (CNF) and large plexiform neurofibromas (PNF). Whole gene deletions of the NF1 gene can cause a more severe phenotype compared to smaller intragenic changes.
Externí odkaz:
https://doaj.org/article/1083c83b07bd4ff4ad4e57786921add6
Autor:
Tim Godel, Philipp Bäumer, Said Farschtschi, Barbara Hofstadler, Sabine Heiland, Mathias Gelderblom, Martin Bendszus, Victor-Felix Mautner
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 780 (2022)
Purpose To examine the spatial distribution and long-term alterations of peripheral nerve lesions in patients with schwannomatosis by in vivo high-resolution magnetic resonance neurography (MRN). Methods In this prospective study, the lumbosacral ple
Externí odkaz:
https://doaj.org/article/f90bb4e35458448bbc712278524158ea
Autor:
Lennart Well, Anna Jaeger, Hildegard Kehrer-Sawatzki, Said Farschtschi, Maxim Avanesov, Markus Sauer, Manuela Tavares de Sousa, Peter Bannas, Thorsten Derlin, Gerhard Adam, Victor F Mautner, Johannes M Salamon
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0232031 (2020)
INTRODUCTION:Patients with Neurofibromatosis type 1 (NF1) develop plexiform neurofibromas (PNF) and cutaneous neurofibromas. These tumors are a major cause of the patient's morbidity and mortality. An influence of estrogen and progesterone on tumor g
Externí odkaz:
https://doaj.org/article/934996fa36674651b57376b0a73cb479
Autor:
Laura Sellmer, Said Farschtschi, Marco Marangoni, Manraj K. S. Heran, Patricia Birch, Ralph Wenzel, Victor-Felix Mautner, Jan M. Friedman
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background Optic pathway gliomas (OPGs) are present in 20% of children with neurofibromatosis 1 (NF1) but are less frequently observed in adults. Our goal was to determine the natural history of OPGs in children and adults with NF1. Results
Externí odkaz:
https://doaj.org/article/176c2e5a10ad4dc6b6f27d2f80f80aea
Autor:
Lennart Well, Anna Careddu, Maria Stark, Said Farschtschi, Peter Bannas, Gerhard Adam, Victor-Felix Mautner, Johannes Salamon
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/f2e4d16628bc45dab3a65f7cb8c566ec
Autor:
Catena Kresbach, Matthias Dottermusch, Alicia Eckhardt, Inka Ristow, Petros Paplomatas, Lea Altendorf, Annika K Wefers, Michael Bockmayr, Sarra Belakhoua, Ivy Tran, Lara Pohl, Sina Neyazi, Helena Bode, Said Farschtschi, Lennart Well, Reinhard E Friedrich, David Reuss, Matija Snuderl, Christian Hagel, Victor-Felix Mautner, Ulrich Schüller
Publikováno v:
Neuro-Oncology.
Background Plexiform neurofibromas can transform into atypical neurofibromas (ANF) and then further progress to aggressive malignant peripheral nerve sheath tumors (MPNST). ANF have been described to harbor distinct histological features and frequent
Autor:
Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Hector Salvador, Amedeo A. Azizi, Victor Mautner, Claas Röhl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink, Joan Brunet, Frank Van Calenbergh, Catherine Cassiman, Thomas Czech, María José Gavarrete de León, Henk Giele, Susie Henley, Conxi Lazaro, Vera Lipkovskaya, Eamonn R. Maher, Vanessa Martin, Irene Mathijssen, Enrico Opocher, Ana Elisabete Pires, Thomas Pletschko, Eirene Poupaki, Vita Ridola, Andre Rietman, Thorsten Rosenbaum, Alastair Santhouse, Astrid Sehested, Ian Simmons, Walter Taal, Anja Wagner
BACKGROUND: Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder, predisposing development of benign and malignant tumours. Given the oncogenic potential, long-term surveillance is important in patients with NF1. Proposals for NF1 care an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6266dfdd6dbf7d811dec26882e62e76
https://lirias.kuleuven.be/handle/20.500.12942/714718
https://lirias.kuleuven.be/handle/20.500.12942/714718
Autor:
Lennart Well, Anna Careddu, Peter Bannas, Said Farschtschi, Victor-Felix Mautner, Maria Stark, Gerhard Adam, Johannes Salamon
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Scientific Reports
Scientific Reports
Neurofibromatosis Type 1 (NF1) has been reported to be associated with a variety of spinal abnormalities. The purpose of this study was to quantify the prevalence of spinal abnormalities in a collective of NF1 patients that is representative for the
Autor:
Lan Kluwe, Said Farschtschi, Andreas Kurtz, Su-Jun Oh, Su-Jin Park, Nancy Mah, Victor-Felix Mautner
Publikováno v:
Cancer Immunology, Immunotherapy
Background Malignant peripheral nerve sheath tumors (MPNSTs) are rare aggressive sarcomas with poor prognosis. More than half of MPNSTs develop from benign precursor tumors associated with neurofibromatosis type 1 (NF1) which is a tumor suppressor ge